Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-adrenergic blockers.

W H Frishman1

  • 1Albert Einstein College of Medicine, Bronx, New York.

The Medical Clinics of North America
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Beta-adrenergic blocking drugs effectively treat cardiovascular conditions like ischemic heart disease and hypertension. These medications offer diverse benefits, including symptom relief and improved survival rates for heart attack survivors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AIDS and the heart: Clinicopathologic assessment.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015
Same author

ACE inhibitors and the arterial wall. Introduction.

Postgraduate medicine·2009
Same author

Pathophysiology and medical management of systemic hypertension and pre-eclampsia in pregnancy.

Minerva medica·2006
Same author

Antiplatelet therapy: glycoprotein IIb/IIIa receptor antagonists.

Drugs of today (Barcelona, Spain : 1998)·2003
Same author

Alcohol as a cardioprotective agent.

Heart disease (Hagerstown, Md.)·2002
Same author

Cardiopulmonary resuscitation 2000.

Heart disease (Hagerstown, Md.)·2002

Area of Science:

  • Pharmacology
  • Cardiology
  • Internal Medicine

Background:

  • Beta-adrenergic blocking drugs are established treatments for cardiovascular and noncardiovascular disorders.
  • This drug class exhibits varied pharmacodynamic and pharmacokinetic profiles.
  • Understanding these properties is crucial for clinical application and managing adverse reactions.

Purpose of the Study:

  • To review the efficacy and applications of beta-adrenergic blocking drugs.
  • To highlight the importance of drug-specific properties in clinical decision-making.

Main Methods:

  • Review of existing literature on beta-adrenergic blocking drugs.
  • Analysis of pharmacodynamic and pharmacokinetic data.
  • Synthesis of clinical evidence for various applications.

Related Experiment Videos

Main Results:

  • Beta-blockers are effective in managing angina and improving exercise tolerance.
  • These drugs successfully reduce high blood pressure.
  • Therapeutic benefits extend to arrhythmias, hypertrophic cardiomyopathy, and post-myocardial infarction survival.

Conclusions:

  • Beta-adrenergic blocking drugs are versatile and essential in cardiovascular medicine.
  • Tailoring drug selection based on individual patient profiles and drug properties optimizes outcomes.
  • These agents significantly improve patient prognosis in multiple cardiac conditions.